39 results on '"Batra, Atul"'
Search Results
2. Prevalence of somatic PIK3CA mutations in hormone receptor-positive metastatic breast cancer: The Indian experience.
3. Prevalence of mutations associated with NCCN criteria for hereditary prostate cancer testing in an Indian population.
4. Outcome with pertuzumab, docetaxel, and trastuzumab (PTH) regimen in patients with HER2 positive metastatic breast cancer: Real-world data from a single center in India.
5. Profile of breast cancer in patients with Li-Fraumeni syndrome: An institutional experience.
6. Topical diclofenac in prevention of capecitabine associated HFS in patients with breast cancer: An exploratory subgroup analysis of the D-ToRCH study.
7. Metformin with neoadjuvant chemotherapy in localized triple negative and HER2neu-positive breast cancer: A prospective phase 2 open label randomised controlled trial (McBETH).
8. Impact of age on the therapy-related characteristics and outcomes of testicular germ cell tumors at a tertiary care center in India.
9. Olanzapine versus fosaprepitant for prevention of chemotherapy induced nausea and vomiting in patients receiving carboplatin (AUC ≥ 4) containing chemotherapy regimen: A phase 3 randomized, double-blind, placebo-controlled trial.
10. Real-world, population-based study of treatments, survival and healthcare use in advanced urothelial carcinoma of the bladder.
11. Prognostic significance of raised serum tumor markers (STM) after 2 cycles of chemotherapy in men with intermediate- and poor-risk non-seminomatous testicular germ cell tumors (NSGCT) treated at a single-centre in India.
12. Physical and psychological symptom burden in patients newly diagnosed with solid organ cancers in a tertiary care centre in India.
13. Comparison of quality of life (QoL) in survivors of testicular nonseminomatous germ cell tumor (NSGCT) with age-matched controls using EORTC QLQ-C30 questionnaire.
14. Real-world treatment patterns, clinical outcomes, and health care resource utilization in advanced unresectable hepatocellular carcinoma.
15. Associations of Socioeconomic Status and Rurality With New-Onset Cardiovascular Disease in Cancer Survivors: A Population-Based Analysis
16. Associations of pre-existing cardiovascular disease (CVD) with treatment patterns and survival outcomes in patients with metastatic prostate cancer: A real-world, population-based study.
17. Randomized double-blind, placebo-controlled study of topical diclofenac in prevention of hand-foot syndrome in patients receiving capecitabine.
18. Seminomatous and non-seminomatous mediastinal germ cell tumors (MGCT): A real-world analysis from two tertiary care centers in India.
19. First-line treatment with a cyclin-dependent kinase 4/6 inhibitor combined with an aromatase inhibitor for hormone receptor-positive, human epidermal growth factor receptor-2 negative metastatic breast cancer: Population-based outcomes for patients treated in Alberta, Canada.
20. Reply to D. O'Reilly et al
21. Differential effect of body mass index (BMI) on outcomes of patients treated with docetaxel in prostate cancer: An exploratory analysis.
22. Associations of education, residence, and travel distance to oncology center on survival outcomes in patients with penile cancer: A tertiary care referral center experience.
23. Revisiting Fulvestrant Dosing in Uncertain Economic Times
24. Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets
25. Associations of rural residence and low socioeconomic status on the risk of new onset cardiovascular disease (CVD) in cancer patients.
26. Eligibility of real-world patients with metastatic lung cancer for clinical trial participation: A population-based analysis.
27. Adjuvant systemic therapies for melanoma in Alberta: An early descriptive analysis of population characteristics and treatment outcomes.
28. Impact of baseline symptom burden as assessed by patient-reported outcomes (PROs) on overall survival (OS) of patients with metastatic cancer.
29. Impact of preexisting cardiovascular disease (CVD) on treatments and outcomes of patients with breast or lung cancer.
30. Use of Twitter among cancer clinicians and researchers and the associations with scientific impact of its users and followers.
31. Referral-to-treatment attrition and its impact on outcomes of patients with advanced gastroesophageal cancers.
32. Real-world eligibility of advanced pancreatic (APC) patients for maintenance olaparib.
33. Eligibility of real-world patients with stage II/III colorectal cancer (CRC) in adjuvant chemotherapy (AC) trials.
34. Oncotype DX: Where Does It Stand in India?
35. Primary CNS Lymphoma in India: A 17-Year Experience From the All India Institute of Medical Sciences
36. Health related quality of life analysis among testicular germ cell tumor survivors treated in a tertiary cancer hospital in India.
37. Pretreatment neutrophilto lynphocyte ratio in ewing sarcoma family of tumors: An analysis of 570 patients.
38. Metronomic therapy versus best supportive care in progressive pediatric solid malignancies: A double blind placebo controlled randomized study.
39. Quality of life assessment in retinoblastoma: A cross-sectional study of 122 survivors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.